Guerbet phases out 2 contrast agents
French contrast developer Guerbet is phasing out worldwide sales of its Optimark...Read more on AuntMinnie.comRelated Reading:
Guerbet invests in French medical technology fund
Guerbet sees 7% growth in Q1 revenue
Guerbet changes labeling for linear MRI contrast agent
Guerbet concurs with gadolinium recommendations
Guerbet, Methapharm sign Canadian deal
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
More News: Canada Health | France Health